ContraFect Corporation announced that in connection with the Restructuring Plan, on November 15, 2023, Roger J. Pomerantz resigned as the Chief Executive Officer of the company. Dr. Pomerantz will remain a member of the Board of Directors of the Company. In connection with the Restructuring Plan, the Board appointed Michael Messinger as the Chief Executive Officer of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0151 USD | 0.00% | +0.67% | -49.67% |
May. 03 | North American Morning Briefing : Apple, Amgen -2- | DJ |
Apr. 26 | North American Morning Briefing : Tech Still in -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-49.67% | 162K | |
+49.21% | 56.87B | |
+36.10% | 39.72B | |
-6.86% | 39.27B | |
-4.42% | 28.73B | |
+12.00% | 26.21B | |
-18.27% | 19.79B | |
+29.57% | 12.28B | |
+25.41% | 12.23B | |
-0.35% | 12.12B |
- Stock Market
- Equities
- CFRXQ Stock
- News ContraFect Corporation
- ContraFect Corporation Announces Chief Executive Officer Changes